Nicole Concin

Nicole Concin is a gynecologic oncologist and translational researcher who has contributed to developing and validating the molecular classification of endometrial cancer (ProMisE: Proactive Molecular Risk Classifier for Endometrial Cancer). She co-led the revision of ESGO/ESTRO/ESP guidelines for endometrial cancer and the FIGO 2023 endometrial cancer staging system that incorporated molecular subgroups. Her research has examined the prognostic implications of p53 mutation and other molecular alterations across endometrial cancer histotypes. Her work is central to modern risk-adapted endometrial cancer management.